March 08, 2026 a 03:43 pm

RVTY: Fundamental Ratio Analysis - Revvity, Inc.

Revvity, Inc. (RVTY) Stock Overview

Revvity, Inc. operates in the rapidly growing markets of diagnostics and life sciences, providing essential tools and technologies for healthcare advancement. Amid a dynamic market landscape, it offers diversified products and solutions that cater to a broad spectrum of scientific research domains. The company’s reputation in innovation makes it a potential long-term asset in investors' portfolios.

Fundamental Rating

The following table provides a breakdown of Revvity, Inc.'s fundamental scores, showcasing its strengths and areas for improvement.

Category Score
Discounted Cash Flow 4
Return On Equity 3
Return On Assets 3
Debt To Equity 2
Price To Earnings 1
Price To Book 3

Historical Rating

Below are the historical fundamental ratings of Revvity, Inc., indicating its financial trajectory.

Date Overall Score DCF ROE ROA Debt/Equity P/E P/B
2026-03-06 3 4 3 3 2 1 3
Historical 0 4 3 3 2 1 3

Analyst Price Targets

Analyst projections provide insight into the potential financial performance of Revvity, Inc.

High Low Median Consensus
$129 $105 $118 $115.14
Revvity, Inc. Stock Chart

Analyst Sentiment

The table below indicates the current analyst recommendations for Revvity, Inc.

Rating Count
Buy 17
Hold 12

Conclusion

Revvity, Inc. is positioned as a strong pick in the medical diagnostics and research sector due to its comprehensive portfolio and innovative solutions. While its price-to-earnings ratio indicates room for valuation improvement, strong cash flow and asset utilization scores suggest financial stability. Analyst consensus leans towards a 'Buy', reinforcing investor confidence. However, potential risks involve sector competition and operational cost challenges. Overall, Revvity presents a viable investment opportunity with promising growth potential.